logo
Log inSign up
logo

AstraZeneca U.S. Manufacturing Investment

Sector: Manufacturing (Industrial) • Location: United States

Source: Reuters

Project
Planned

AstraZeneca will invest $50 billion on U.S. manufacturing by 2030, including a new drug substance facility in Virginia and expansions in Maryland, Massachusetts, California, Indiana, and Texas.

Status
Prospective
Sector
Manufacturing (Industrial)
Location
United States of America
Updated
22 Jul 2026
Source
Reuters

ConstructChat

Ask ConstructChat about AstraZeneca U.S. Manufacturing Investment

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “AstraZeneca U.S. Manufacturing Investment” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in United States. Taiyo aggregates data on it from Reuters.

Participants

Not available for this record.

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

AstraZeneca will invest $50 billion on U.S. manufacturing by 2030, including a new drug substance facility in Virginia and expansions in Maryland, Massachusetts, California, Indiana, and Texas.

Original sector

Healthcare & Pharmaceuticals

Budget

Location

Country

United States of America (USA)

Source

Source

Reuters

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2025-11-21

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project